Utility of 90-Day Mortality vs 30-Day Mortality as a Quality Metric for Transcatheter and Surgical Aortic Valve Replacement Outcomes

IMPORTANCE: Questions have recently arisen as to whether 30-day mortality is a reasonable metric for understanding institutional practice differences after transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR). OBJECTIVE: To examine the utility of 30-day vs 90-da...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:JAMA Cardiol
Main Authors: Hirji, Sameer, McGurk, Siobhan, Kiehm, Spencer, Ejiofor, Julius, Ramirez-Del Val, Fernando, Kolkailah, Ahmed A., Berry, Natalia, Sobieszczyk, Piotr, Pelletier, Marc, Shah, Pinak, O’Gara, Patrick, Kaneko, Tsuyoshi
Formato: Artigo
Idioma:Inglês
Publicado em: American Medical Association 2020
Assuntos:
Original Investigation
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6990722/
https://ncbi.nlm.nih.gov/pubmed/31851293
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamacardio.2019.4657
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados